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2Abstract
The formation of the neuromuscular junction is characterized by the progressive
accumulation of nicotinic acetylcholine receptors (AChRs) in the postsynaptic membrane
facing the nerve terminal, induced prominently through the agrin/MuSK signaling cascade.
However, the cellular mechanisms linking MuSK activation to AChR clustering are still
poorly understood. Here, we investigate whether lipid rafts are involved in agrin-elicited
AChR clustering in a mouse C2C12 cell line. We observed that in C2C12 myotubes both
AChR clustering and cluster stability were dependent on cholesterol since depletion by
methyl--cyclodextrin inhibited cluster formation or dispersed established ones. Importantly,
AChR clusters resided in ordered membrane domains - a biophysical property of rafts - as
probed by Laurdan two-photon fluorescence microscopy. We isolated detergent-resistant
membranes (DRMs) by three different biochemical procedures, which all generate
membranes with similar cholesterol/GM1 ganglioside contents and were enriched in several
postsynaptic components, notably AChR, syntrophin and raft markers flotillin-2 and caveolin-
3. Agrin did not recruit AChRs into DRMs, suggesting that they are present in rafts
independently of agrin activation. Consequently, in C2C12 myotubes, agrin likely triggers
AChR clustering or maintain clusters through the coalescence of lipid rafts. These data led us
to propose a model in which lipid rafts play a pivotal role in the assembly of the postsynaptic
membrane at the neuromuscular junction upon agrin signaling.
KeyWords : agrin, C2C12 myotubes, lipid rafts, nicotinic acetylcholine receptor,
neuromuscular junction.
3Introduction
During synapse differentiation at the neuromuscular junction, motor innervation
recruits nicotinic acetylcholine receptors (AChRs) to the sites of nerve-muscle contact. AChR
clustering is stimulated by the neuronally released, extracellular matrix associated, heparan
sulfate proteoglycan agrin (reviews in 1-3). The activity of agrin in AChR clustering is
mediated by a signaling machinery that includes the agrin receptor MuSK (muscle-specific
tyrosine kinase receptor; 4), the AChR-associated peripheral protein rapsyn (review in 2) as
well as several intracellular enzymes (review in 5). However, the mechanisms linking MuSK
activation to AChR clustering at the cell surface are still poorly understood. Once activated,
MuSK recruits several effectors that are known to reorganize actin cytoskeleton (review in 5).
Yet, interaction of AChRs with the actin membrane cytoskeleton provides both aggregation
and restricted diffusion within the lipid bilayer (6-9). However, other mechanisms could also
provide AChR segregation such as partitioning within specific lipid domains.
Cholesterol-sphingolipid-enriched lipid rafts form dynamic liquid ordered
microdomains that float freely within the fluid, liquid disordered, cellular membranes. By the
nature of their structure, these domains selectively incorporate or exclude proteins and
therefore have been proposed to function as membrane platforms for the assembly of
signaling complexes and for membrane sorting (10). Due to their highly dynamic structure
these submicroscopic assemblies are able to coalesce upon clustering of their components, in
physiological conditions by protein-driven interactions involving for example caveolins (11)
or reorganization of actin cytoskeleton (12, 13) , and artificially by crosslinking with
antibodies or cholera toxin B subunit (CTX), a specific ligand of GM1 ganglioside (14, 15).
For AChR aggregation, raft clustering might be required to generate synaptic clusters of
neurotransmitter receptors characteristic of postsynaptic sites.
Insolubility in cold non-ionic detergent and perturbation of cellular process by
cholesterol depletion with methyl--cyclodextrin (MCD) have been used as tools to study
the role of rafts in cell signaling and function, in particular in the maintenance and/or
formation of central synapses (16). In the central nervous system, several postsynaptic
proteins including neuronal 7-AChR, GABA B receptor, NMDA and AMPA receptors,
voltage gated K+ channel Kv2.1, postsynaptic density (PSD)-95 and glutamate receptor-
interacting protein (GRIP) are partially associated with Triton X-100-resistant membranes
4(17-21). Lipid rafts exist abundantly in dendrites of cultured hippocampal neurons in which
postsynaptic proteins including AMPA receptors are enriched. Depletion of
cholesterol/sphingolipids leads to instability of these receptors and gradual loss of synapses
and dendritic spines (19). Similarly, in ciliary ganglion neurons and in PC12 cells, lipid rafts
are necessary for the specific localization and stabilization of 7 nicotinic AChR within the
plasma membrane (18, 20). Interestingly, Oshikawa et al, (20) showed that the fractionation
of PC12 cells resulted in the differential distribution of various AChR subunits : 7, which
forms postsynaptic homopentameric AChRs, was recovered in DRM fraction, whereas non
synaptic 5 and 2 subunits were not. Thus, lipid rafts may be required to localize specific
receptors to synaptic sites. A similar approach applied to transiently transfected COS-7 cells
allowed us to demonstrate that muscle nicotinic AChR and rapsyn are cotransported in the
exocytic pathway from the Golgi apparatus to the cell surface within lipid rafts (22). More
recently, Campagna and Fallon (23) reported that in C2C12 myotubes CTX favors agrin-
induced AChR clustering and that depletion of cholesterol disrupts AChR aggregates,
supporting the notion that lipid rafts contribute to synaptic organization at the NMJ.
As cold detergent extraction may cause artefactual lipid aggregation and cholesterol
depletion may not be specific to rafts (24, 25), alternative microscopic techniques such as
FRET, Laurdan 2-photon microscopy and single particle tracking as well as detergent-free
purification procedures have been developed to study raft properties. Here we combine a
number of these approaches to study the agrin-induced AChR clusters of C2C12 myotube
plasma membrane. We use immunofluorescence to quantify AChR clustering and the
fluorescent lipid dye Laurdan in conjunction with 2-photon laser scanning microscopy for the
biophysical characterization of AChR clusters. Laurdan’s fluorescence emission spectrum
depends on the fluidity of its membrane environment (26) and this approach was used to
verify the cholesterol dependency of AChR clustering. Further, we analyzed DRMs from
C2C12 myotubes and compared them to two alternative detergent-free extraction procedures.
The biochemical data showed that AChR fractionated within light cholesterol-enriched DRMs
independently of agrin treatment. Taken together, these data indicate that in muscle fibers
lipid raft coalescence may serve as signaling platforms to concentrate AChRs at synaptic sites
following agrin/MuSK activation.
5Materials and methods
Antibodies and reagents
Mouse monoclonal (mAb) anti-syntrophin (mAb 1351E; 27) anti-rapsyn (mAb 1234;
28) antibodies were provided by Pr. S. Froehner (University of Washington, Seattle, WA) or
purchased from Abcam, UK. mAb anti-transferrin receptor (H 68.4) was a gift from Pr. J.M.
Trowbridge (UCSD, San Diego, CA). mAb anti-AChR -subunit (clone 26), anti-flotillin-
2/epidermal-surface antigen (ESA), and anti-caveolin-3 antibodies were obtained from
Transduction Laboratories (Lexington, KY). Cholera toxin B, anti-cholera toxin B, anti--
tubulin, methyl--cyclodextrin (MCD) and Triton X-100 were purchased from Sigma (St
Louis, MO). The following reagents and antibodies were used for immunofluorescence:
fluorescein isothiocyanate (FITC) and Alexa 555-conjugated -bungarotoxin (-Bgtx) and
Laurdan (6-dodecanoyl-2-dimethylaminonapthalene) were from Molecular Probes Inc.
(Eugene, OR, USA), RITC-conjugated secondary antibodies were from Jackson
Immunoresearch (West Grove, PA).
Cell cultures
The culture of C2C12 cell line (adult C3H mouse leg muscle, ATCC Catalog No
CRL-1772, Manassas, VA) was initiated with 10% fetal bovine serum in DMEM medium
(Gibco, Eggenheim, Germany) complemented with 100 units/ml penicillin and streptomycin,
0.5% glutamine (v/v) for 3 to 4 days. Myotube differentiation was achieved in 3% horse
serum (HS) in DMEM medium supplemented with 100 units/ml penicillin and streptomycin,
0.5% glutamine (v/v) during 5 to 7 days. AChR clustering was elicited by overnight
incubation with 5 ng/ml recombinant 90 kDa C-terminal rat agrin (C-Ag 3,4,8) purchased from
R&D Systems (Minneapolis, MN). For immunofluorescence studies, cells were plated on
glass coverslips covered with a thin layer of Matrigel® (Becton Dickinson, Bedford, MA)
into a 6-well plate. For biochemical studies, cells were grown in 75 cm
2
flasks. All cell
cultures were maintained at 37°C in a humidified air atmosphere containing 5% CO2.
Drug treatments
The depletion of cholesterol from C2C12 myotube membranes was performed by
incubation of cultures with MCD (10 mM) for 30 min at 37°C (14, 18). After washing, the
6cells were processed either for AChR and Laurdan labeling or for AChR quantification as
indicated (see below).
Preparation of DRM fractions from C2C12 myotubes
Three different methods were used to purify DRM fractions from differentiated
myotubes: the traditional non-ionic detergent (Triton X-100) at 4°C (29), detergent-free at pH
11 (30) or shearing in an isotonic buffer containing Ca
++
/Mg
++
(31).
Triton X-100: fully differentiated C2C12 myotubes were washed in PBS, and with buffer A
(25 mM N-morpholino-ethane-sulfonic acid pH 7.4 containing 150 mM NaCl and 2 mM
EDTA). The cells were then suspended in ice-cold 1% Triton X-100 (protein/detergent ratio
of 1/1 (wt/wt)) in 2 ml buffer A supplemented with a protease inhibitor cocktail (1 μg/ml
leupeptin, 1 μg/ml pepstatin, 1 mM benzamidin, 3 μg/ml aprotinin, 2.5 μM
phenylmethylsulfonyl fluoride (PMSF)), homogeneized with 12 to 15 strokes of a Dounce
homogenizer and incubated 1 h on ice.
Alkaline extraction: C2C12 myotubes were homogenized in 0.5 M sodium carbonate pH 11
(30). Following sodium carbonate extraction, cells were sonicated 3  2 min on ice in a bath
sonicator.
For both extraction protocols, an equal volume of sucrose 80% (w/v) in buffer A was added to
the cell lysates (2 ml) and placed in the bottom of an ultracentrifugation tube. Cell lysates
were overlayed successively with 4 ml 30% sucrose and 4 ml 5% sucrose in buffer A
(supplemented 250 mM sodium carbonate for detergent-free extraction protocol). After
centrifugation at 39, 000 rpm in a Beckman SW41 Ti rotor for 18 h at 4°C, 1 ml fractions
were collected from top to bottom (designated 1 to 12).
A third simplified method adapted from Macdonald and Pike (31) was used: myotubes were
washed in buffer P (20 mM Tris, pH 7.8, 1 mM CaCl2, 1 mM MgCl2) containing 250 mM
sucrose and homogenized with 20 strokes of a Dounce homogenizer. Cells were then lysed in
P buffer supplemented with anti-proteases by 5 passages through a 18G x 1 1/2’’ needle
followed by 15 passages through a 21G x 2’’ needle. Lysates were centrifuged at 1,000 g for
10 min. The resulting post nuclear supernatants were collected and saved. The pellet was
again lysed and centrifuged. Both supernatants were combined and mixed with an equal
volume of sucrose 80% (w/v) in buffer P and placed in the bottom of an ultracentrifugation
tube. Cell lysates were overlayed successively with 2 ml 35%, 2 ml 30 %, 2 ml 20% and 2 ml
5% sucrose in buffer P free of sucrose and gradients were centrifuged at 39, 000 rpm in a
Beckman SW41 Ti rotor for 18 h at 4°C.
7Western and dot blot analyses
Proteins from gradient fractions were precipitated with 10% trichloracetic acid,
washed with 80% cold acetone, dissolved in Laemmli buffer (32), separated on 10% SDS-
PAGE (Mini Protean II, Bio Rad, Richmond CA, USA), and electrotransferred onto
nitrocellulose paper (Schleicher and Schuell, Dassel, Germany). Western blots were probed
using various primary antibodies: anti-AChR subunit (1:300); anti-rapsyn (1:400), anti-
caveolin-3 (1:15, 000); anti-flotillin-2/ESA (1:7, 500); anti-syntrophin (1:10, 000); anti-
transferrin receptor (1: 3000) and anti- tubulin (1: 30, 000), and appropriate HRP-conjugated
secondary antibodies with enhanced chemoluminescent detection (ECL, Amersham
Pharmacia Biotech) and exposure to Fuji X-ray films. To reveal the distribution of GM1 in
the gradients, 50 μl of each fraction before TCA precipitation were spotted on nitrocellulose
membrane using a BioRad Dot Blot apparatus. GM1 was detected with Cholera toxin B and
anti-cholera toxin B antibodies, followed by ECL detection.
Immunofluorescence Microscopy
C2C12 myotubes were rinsed with PBS and fixed at 4°C for 15 min with 3%
paraformaldehyde in 0.1 M phosphate buffer, pH 7.4. Fixed cells were rinsed with PBS, and
where needed (for immunodetection of flotillin-2 or caveolin-3) permealized with 0.1%
Triton X-100 in PBS for 5 min at room temperature (or with methanol 95% for 5 min at -
20°C) and washed. After preincubation for 30 min at room temperature in PBS containing 1%
bovine serum albumin (BSA) and 5% goat serum (GS), C2C12 myotubes were incubated for
1 h at room temperature with primary antibodies: anti-caveolin-3 (1:400) or anti-flotillin-
2/ESA (1:100) in PBS supplemented with 0.1% BSA and 0.5% GS, then rinsed 3x with PBS
for 5 min and incubated with the secondary antibodies for 30 min at room temperature (RITC-
conjugated goat anti-mouse, 1:400). In all experiments, AChR detection was achieved by
FITC-conjugated -Bgtx (3 μg/ml). Before observation, samples were mounted in Citifluor
(UKC. Chemlab). Micrographs were taken with a Leica DMR microscope (Leica Systems)
equipped with PL Fluotar x40 or Plan Apo x63 oil immersion optics and a Micro Max cooled
CCD camera (Princeton Instruments, Inc.) operating at full resolution. Digital images were
recorded using Meta View Imaging System (Universal Imaging Corp.) and prepared for
publication using Adobe Photoshop.
8Laurdan 2-Photon microscopy
Differentiated C2C12 myotubes were labeled with Laurdan by incubating washed cells
(1% HS in DMEM) with 5 μM Laurdan in 1% HS in DMEM for 30 min at 18°C or 37°C.
Myotubes were washed in PBS, fixed with 3% paraformaldehyde in 0.1 M phosphate buffer,
pH 7.4. After washing, cells were labeled with Alexa 555-conjugated -Bgtx (3 μg/ml,
Molecular Probes), washed and mounted in CityFluor. Multi-photon excitation of Laurdan
fluorescence was at 800 nm with a Verdi/Mira 900 laser system and intensity images were
recorded simultaneously in the range of 400-450 nm and 450-530 nm with a Biorad
microscope. The relative sensitivity of the two channels was calibrated with 5 μM Laurdan in
DMSO for each experiment. For confocal microscopy a helium-neon laser was used to excite
Alexa 555 with appropriate cut-off filters and pinhole widths. For all images, a 100x oil
objective, NA=1.4 was used. Alexa IF stain was imaged first and then Laurdan at the same
focal depth. For Laurdan image analysis, all calculations were carried out in floating point
format and images converted into 8-bit unsigned images for presentation using the imaging
software WIT. The Generalized Polarization (GP), defined as:
GP = I(400-450)  I(450-530)
I(400-450) + I(450-530)
was calculated for each pixel using the two Laurdan intensity images. GP images were pseudo
colored in Adobe Photoshop. To determine GP values at -Bgtx clusters, confocal images
were used to mask the GP images; the confocal images defined the regions of interest (ROI)
and the mean GP value of the ROI was determined for each image. GP values were corrected
using the G-factor obtained for Laurdan in DMSO for each experiment (33).
Image quantification
To determine the line profiles of the AChR clusters, a line was drawn along the main
axis of myotubes and the fluorescence intensity was plotted versus relative distance using
Image J software 1.26t (NIH, Bethesda, MD). To estimate the magnitude of the effect of drug
treatments on AChR clusters, the number and the average size of clusters were measured
using a calibrated mesh. The average length of AChR aggregates l was estimated according
to:
l=.n.d/4N,
9where n is the number of intersections between clusters and the mesh , d the size of the mesh,
and N the total number of clusters. For each experiment 5 optical fields selected at random
were analyzed at a magnification of 1600x.
Quantification of proteins and cholesterol
The total amount of proteins in the C2C12 cells as well in the various fractions
collected from the gradients was determined according to the Pierce protocol of the ‘BCA
TM
Protein Assay Reagent kit’ (Rockford, IL). Cholesterol quantification was based upon
cholesterol oxidase method for cholesterol determination by spectrophotometry using Thermo
Trace assay (Thermo Electron Corporation, Melbourne, Australia). Calibration was done with
aqueous standard solutions of cholesterol (Thermo Electron Corporation, Melbourne,
Australia). For total cholesterol determination in C2C12 myotubes, cells were previously
washed in lipid-free synthetic culture medium (DMEM) and lysed by Triton X-100.
Quantification of AChR in C2C12 myotubes
Quantification of AChR (34, 35) expressed at the cell surface was determined by
incubating fixed (3% paraformaldehyde, 10 min at 4°C) differentiated C2C12 myotubes with
125
I--Bgtx. For intracellular AChR quantification, fixed C2C12 myotubes were incubated
with cold -Bgtx (5 nM) for 1 h at 4°C to block the -Bgtx binding sites of the cell surface,
then permealized with Triton 0.1% for 5 min. Total pool of AChR was carried out on cells
also permealized with Triton 0.1%. For cell surface, intracellular and total AChR
quantification, cells were incubated for 2 h on ice with 5 nM
125
I--Bgtx (Amersham
Biosciences ; 150 Ci/mmol) in PBS containing 1 mg/ml BSA, followed by three washings on
ice with PBS/BSA. Cells were lysed in PBS containing 1% SDS at 37°C for 1 h. Cells lysates
were collected and
125
I radioactivity was counted for 1 min on a MR480 gamma counter
(Kontron Electronik, Eching, Germany). Non-specific binding determined after competition
of
125
I--Bgtx binding with a large excess of cold -Bgtx (5μ) was generally less than 5-
10%. Each experiment was done in triplicate. In all experimental conditions, we verified that
the same amount of total protein was present and expressed the data as percent of total AChR
in control myotubes.
10
Negative staining electron microscopy
Samples of DRM fractions directly taken from the gradients were supplemented with
10 μg/ml bacitracine (Sigma). Ten μl drops were then deposited onto carbon-coated EM
grids. Negative staining was achieved by washing the grids with 100 μl of 1% (wt/vol) uranyl
acetate in water and dried with filter paper. Grids were observed in a Philips (Eindhoven, the
Netherlands) EM12 electron microscope fitted with a LaB6 filament and operation at 80 keV.
Micrographs were taken on Kodak electron microscope films.
11
Results
Cholesterol is required for AChR clustering in C2C12 myotubes
As lipid rafts are enriched in cholesterol, the removal of cholesterol from cell
membranes causes the dispersion of lipid rafts within the fluid phase of the cell membrane
and perturbs signaling efficiency (14, 18, 36). To determine whether cholesterol-enriched
lipid domains are involved in AChR clustering, we used MCD, a useful tool that has been
shown to extract cholesterol from biological membranes with high preference over other lipid
species, to selectively deplete cholesterol from the cell membrane in C2C12 myotubes.
Similar to what is reported with other cells, MCD treatment (10 mM, 30 min) of C2C12
myotubes released approximately 60% of total cellular cholesterol. We thus addressed
whether MCD treatment perturbs already established AChR aggregates, which were
previously induced by agrin at the surface of myotubes. In myotubes incubated overnight with
agrin, numerous AChR clusters measuring up to 10-20 μm (mean length 4.0±1.0 μm) were
detected at the surface of myotubes by fluorescence microscopy using FITC-conjugated -
Bgtx as a marker for AChRs (Fig. 1A). In cholesterol-depleted cells small dispersed AChR
aggregates with a mean size of 1.3±0.2 μm were observed instead of the large AChR clusters
(Fig. 1B). Plots of line profiles along the main axis of myotubes showing the fluorescence
intensity versus distance illustrated the dispersion of AChR clusters into smaller patches
following MCD treatment (Fig. 1C and D corresponding to Fig. 1A and B, respectively),
which does not result in a larger number of smaller clusters. For control cultures we found 47
clusters/field ± 8, n=5 and 58 clusters/field ± 10, n=3 after MCD treatment. In a second
series of experiments we asked whether the presence of cholesterol is required for agrin-
induced AChR clustering. We thus deplete cholesterol from myotubes using MCD before
induction of AChR clustering by agrin. In these conditions, no large AChR clusters (4 μm)
were observed (Fig. 1 F, E= control). Cholesterol-depleted myotubes were thus no longer able
to form typical AChR clusters as recently reported by Campagna and Fallon (23).
In previous works by us and others (22, 37, 38), raft lipids have been shown to be
required for intracellular trafficking and surface transport of AChRs. To ascertain the
implication of lipid rafts on agrin-elicited AChR clustering, rather than the effect of the
depletion in cholesterol on AChR biosynthesis or/and surface expression, we quantified
surface, intracellular and total AChRs in control and MCD-treated myotubes by means of
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I--Bgtx binding. We observed that MCD-treated myotubes exhibit similar total AChR
content (93±13% versus 100±19%, n=6 for MßCD-treated myotubes and control,
respectively), cell surface (49±14% versus 53±14%, n=3) and intracellular (47±21% versus
60±15%, n=3) AChR, as compared to controls (all data were expressed as percent of total
AChR in control myotubes =100%). These data show that in our experimental conditions (10
mM MCD, 30 min) cholesterol depletion of myotubes has no major effect on AChR
biosynthesis, surface transport or internalization. We thus concluded that cholesterol is
required for the agrin-elicited AChR clustering.
AChR clusters correspond to condensed membrane domains of the myotube surface
So far, our data in agreement with other reports (23) suggest a role of cholesterol in
AChR clustering. Lipid rafts, as entity, constitute a highly ordered membrane domain that is
distinct from the more fluid surroundings. To demonstrate that AChR-rich microdomains
indeed correspond to ordered domains, we applied Laurdan 2-photon fluorescence
microscopy, which allows the direct visualization of membrane order (26). To assess the
degree of lipid condensation at AChR clusters, C2C12 myotubes were labeled with Laurdan
before or after agrin induction, imaged and the intensity images converted into Generalized
Polarization (GP) images as previously reported (33, 39). Regions of high GP values (0.25 to
0.55) corresponded to ordered domains (colored yellow to red) while low GP (-0.05 to 0.25)
corresponded to fluid domains (colored green). Figure 2 showed control (A-C) and agrin-
treated myotubes (D-F) labeled with Laurdan and -Bgtx. In control cells (A, C), no regions
of high GP were detected (mean GP= 0.234 ± 0.028 ; n=24, see Table). In agrin-treated
myotubes (D, F), GP values of -Bgtx labeled AChR clusters were significantly increased
(mean 0.303 ± 0.088 n=38, P<0.001) with peak values reaching 0.6 to 0.8 (see line plot in F).
The line plot (F) shows the profile of GP values and -Bgtx fluorescence intensities across
three AChR clusters (E) indicating that high GP regions were associated with most AChR
clusters (open arrows). However, some AChR clusters did not correspond to particularly
condensed membrane domains (filled arrow in Fig. 2F). Labeling myotubes at 18˚C to block
endocytosis (see Table) yielded the same results with mean GP values of agrin-induced AChR
clusters of 0.312 ± 0.065 indicating that AChR clusters reside in ordered membrane domains
at the cell surface. Furthermore, cholesterol depletion with MßCD (10 mM, 30 min) before or
after agrin treatment (G-I) significantly decreased the mean GP value of toxin-stained
membranes (J-L) when compared to control, agrin-treated myotubes (see Table). Importantly,
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MßCD treatment did not globally reduce membrane structure below control membranes
(compare average GP value in I and L to C), suggesting that MßCD treatment was specific to
cholesterol-enriched domains. We conclude that agrin-induced AChR clusters resemble lipid
rafts biophysically and that the formation, size and structure of membrane domains after agrin
signaling are dependent on cholesterol.
AChR partitions within DRMs in C2C12 cells
The biochemical characterization of lipid rafts from various cell types has been mainly
facilitated by isolation procedures based on their relative insolubility in cold, non-ionic
detergents (typically 1% Triton X-100). However, it has become clear that detergent treatment
itself can induce the formation of lipid domains, which do not exist in the native membranes
prior to detergent extraction. To circumvent a possible artefactual association of AChR with
DRMs, alternative detergent-free extraction procedures have been developed (30, 31). Here
we used three different extraction protocols to characterize synaptic components in DRM
fractions purified from cultured muscle cells. In a first approach, we applied the standard
Triton X-100 extraction protocol on C2C12 myotubes to isolate DRMs in a 5/30/40%
discontinuous sucrose density flotation gradient. Fractions were analyzed for total protein and
raft lipids (cholesterol and GM1 ganglioside, Fig. 3A). Relatively little protein was present in
the light/DRM fractions (fractions 4-6 corresponding to the 5/30% interface), the bulk of the
proteins being found in the dense fractions, as generally reported. Conversely, cholesterol and
GM1 levels were high in the DRM fractions (about 150 μg cholesterol/mg protein) compared
to high-density fractions (10-20 μg cholesterol/mg protein). These properties are typical
characteristics of rafts/DRMs. We further characterize these fractions by immunoblotting
using antibodies against known raft proteins such as caveolin-3, the muscle isoform of
caveolin (40), and flotillin-2/epidermal surface antigen (ESA), the flotillin isoform
upregulated during the differentiation of skeletal myoblasts (41). As shown in Figure 3 B,
these two markers are enriched in fractions 4-6, as expected for DRMs. Further, light
fractions, which displayed canonical biochemical properties of lipid rafts also contained
robust amounts of AChR. Interestingly, the signaling/adapter protein syntrophin, a
postsynaptic protein concentrated at AChR-rich sites in skeletal muscles (27, 42) was also
recovered in DRM fractions. Small amounts of rapsyn were also detected in these fractions.
Conversely, the non-raft proteins tubulin and transferrin receptors are present almost
exclusively in the heavier fractions of the gradient. Consistent with other reports (43, 44), we
also observed that the protein/detergent (Triton X-100) ratio was critical for AChR
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partitioning in DRMs. A minimal protein/detergent ratio of 1/1 (wt/wt) was required to
recover AChRs within light fractions of the gradients as DRMs. The present data are in
agreement with a previous work carried out in transiently transfected COS-7 cells, in which
we showed that the majority of AChR was recovered in TritonX-100-resistant membranes
(22).
Because DRMs were isolated from post-lysis membranes, which might either induce
the formation of lipid domains or exclude proteins that are weakly associated with rafts, we
used alternative detergent-free methods for DRM isolation: extraction of myotubes by sodium
carbonate, pH 11/ sonication (30) shown in Fig. 4 or a simplified extraction method using
shearing of cells in a divalent cations buffer (calcium/magnesium buffer; 31) shown in Fig.5.
In alkaline extracted myotubes, the distributions of cholesterol, GM1 and total protein along
the gradients as well as the cholesterol/protein ratio of the light fractions (5/30% interface,
Fig. 4) were similar to those obtained after Triton X-100 extraction (Fig. 3A). AChR was
almost totally recovered in low buoyancy fractions (Fig. 4B) together with raft markers
flotillin-2 or caveolin-3. Again, part of rapsyn immunoreactivity was recovered in DRMs.
Extraction in Ca
++
/Mg
++
buffer, according to Macdonald and Pike (31) resulted in the
isolation of a cholesterol-rich fraction at the 30% to 35% interface of the sucrose gradient in
which flotillin-2 and AChR are totally recovered (Fig. 5B). Compared to the two other
purification procedures, a slight shift towards the light fractions was observed for GM1
ganglioside compared to cholesterol (Fig. 5A). Note that the highest intensities of AChR and
flottilin immunoreactivities were more coincident with cholesterol-enriched fractions than
with GM1-enriched ones. This shift of GM1 could result from the more analytical sucrose
gradient which allows a fine separation of subclasses of DRMs with different
cholesterol/GM1 ratios. Taken together, the biochemical analysis of DRMs obtained from
three extraction procedures based on different biochemical principles, demonstrated that
AChR, syntrophin, rapsyn and possibly other synaptic components such as MuSK (data not
shown) are associated with raft-like membrane domains.
Electron microscopic examination of the DRM samples derived from the three
extraction procedures (Fig.6) disclosed vesicular profiles with diameters ranging from 0.1 to
0.5 μm. Such structures are similar to those of PSD-70-enriched dendritic raft fraction
isolated from rat forebrain (44). The Ca
++
/Mg
++
fraction was more homogenous than the two
others and differed in vesicle mean diameter (0.1 to 0.2 μm). Given the small size attributed
to native rafts in situ (46), these large DRM vesicles likely correspond to aggregates of raft
domains.
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To assess whether agrin recruits AChR into rafts, we analyzed the DRM fractions
obtained from control and agrin-treated myotubes. In all extraction conditions (Triton X-100,
pH 11 and Ca
++
Mg
++
buffer), we were not able to detect any significant difference in the
distribution patterns of AChRs along the gradients (Fig. 7) between control and agrin-treated
myotubes. We conclude that AChRs are constitutively associated with cholesterol-rich
membrane domains and that agrin did not significantly contribute to translocation of AChR
into lipid rafts.
AChRs, caveolae and flotillin-enriched rafts segregated as distinct microdomains at the cell
surface of myotubes upon agrin engagement
In mammalian cells several classes of rafts have been described, most prominently
caveolin-containing membrane invaginations (caveolae) or non-caveolin-containing rafts (47).
Owing to their specific biochemical composition, all DRMs display similar buoyancy and
therefore cannot be separated by current gradient flotation centrifugation. It is likely that all
proteins enriched in the light fractions from C2C12 myotubes resulted from the accumulation
of the various raft subclasses. In order to determine whether caveolin, flotillin and AChR are
present in specialized subclasses of rafts, in situ, we studied the localizations of AChR
clusters, caveolin-3, and flotillin-2 by immunofluorescence microscopy in C2C12 myotubes
following agrin treatment. Figure 8 shows that caveolin-3 (A, B) as well as flotillin-2 (C)
were both excluded from agrin-elicited AChR clusters. A similar mutual exclusion between
AChR and caveolin-1-rich membrane domains has previously been observed in transfected
COS-7 cells (22). We thus conclude that upon agrin engagement, AChR-enriched rafts
become clustered at the cell surface independently of caveolin-3 or flotillin-2-enriched raft
subclasses. The present data suggest that several functionally specialized subsets of rafts
coexist at the surface of myotubes, and that AChR clustering results from the regulated
coalescence of one (or a few) distinct raft subclass (es), enriched in postsynaptic components.
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Discussion
Cholesterol- and sphingolipid-enriched microdomains or lipid rafts have been added to
the bilayer model to explain lateral segregation within cellular membranes. As such, lipid rafts
would regulate local concentrations of membrane proteins and lipids. Accordingly rafts have
been implicated in protein and lipid sorting and trafficking, vesicle formation and docking,
entry and exit of pathogens as well as in receptor-mediated cell signaling (48, 49). Because
lipid rafts can move laterally and cluster into larger patches (39), they have been proposed to
play a role in the redistribution of specific molecules to specialized cellular structures. Indeed,
rafts have been shown to favor formation and maintenance of synaptic receptor clusters in
neurons of the central nervous system (17-20) and in myogenic cells (23).
Here we showed that in C2C12 myotubes, agrin-elicited AChR clusters correlated
with condensed membrane domains - the biophysical hallmark of lipid rafts. Further, we
demonstrated that the formation of AChR clusters and their size, as well as the structure of the
membrane domains they reside in, depend on cholesterol. We also report that three different
extraction procedures generated DRMs with high cholesterol/GM1 ganglioside content, which
are enriched in several postsynaptic components, notably AChR, syntrophin and raft markers
flotillin-2 and caveolin-3. Interestingly, agrin did not recruit AChR into DRMs suggesting
that AChR is present in rafts independently of agrin activation. Taken together, the present
data suggest that lipid rafts represent platforms for AChR clustering at the neuromuscular
junction.
A major goal of the present study was to establish whether condensation of membrane
domains or ordered membrane phases, by definition lipid rafts, correlate to AChR aggregation
in myotubes upon agrin engagement. Laurdan fluorescence microscopy has been instrumental
in quantifying the formation membrane order and defining cellular requirements of condensed
membrane domains (26). By visualizing lipid structure and raft domains in living cells,
Laurdan 2-photon microscopy provided strong support for the lipid raft hypothesis. Generally,
live or fixed cells displayed two distinct plasma membrane regions. Those with a mean GP of
0.10-0.25 correspond to liquid-disordered phases and regions with a mean GP of 0.35 to 0.55
correspond to liquid-ordered phases (33, 39, 50). Our experiments reveal that AChR clusters
in agrin-treated myotubes are associated with mean GP values (0.303 ± 0.088 at 37°C and
0.312 ± 0.065 at 18°C) statistically higher than the membrane of untreated myotubes (0.234 ±
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0.028). Some discrete regions have a much higher GP up to 0.6/ 0.8, matching with Alexa-
conjugated -Bgtx staining (see Fig. 2 F). However, some well-defined AChR clusters,
although showing a lower -Bgtx staining, exhibited a lower GP. These regions probably
accounted for the lower mean GP value of AChR clusters. These data are in agreement with
early studies by the Barrantes group on the high lipid order of AChR-rich postsynaptic
membranes from Torpedo fish as studied by Laurdan spectroscopy (51).
This technique also allowed us to assess the effect of cholesterol depletion on lipid
structure in myotubes. In good agreement with dispersion of AChR cluster or inhibition of
AChR clustering upon MCD treatments, GP values also significantly decreased to quasi-
disordered membrane phases. Because of its limited resolution (183 nm at 800 nm excitation
wavelength), the 2-photon technique is not presently capable of visualizing individual rafts of
estimated diameter 30 to 50 nm. Consequently, we cannot discriminate between a
disappearance of AChR rafts from the cell surface and a dispersion of AChR clusters into
unresolved small rafts upon cholesterol depletion. The data strengthen our conclusion that
AChR-enriched membrane domains are cholesterol dependent. This is in agreement with
other reports (23) but in contrast to raft coalescence in T cells where MßCD treatment
diminished membrane order but did not abolished it (39).
Although raft biochemical extraction have raised controversies (52, 53), the
demonstration by Gaus et al. (44) that THP-1 macrophages treated either by 0.2% Triton or
sonication yield membranes of similar lipid structure, prompted us to biochemically
investigate rafts from C2C12 myotubes. We show here that three different biochemical
preparations of DRM fractions using either cold Triton X-100 or detergent-free extraction
procedures (Fig. 3 to 6) yielded vesicular light fractions showing a remarkable similarity as
they are enriched in raft lipids (cholesterol and ganglioside GM-1), in the raft markers
caveolin-3 and flotillin-2, and in AChR. These DRMs also contained syntrophin as well as a
small part of rapsyn and MuSK (data not shown), pointing to the possibility that the
regulation of AChR clustering at synaptic sites by the agrin/MuSK/rapsyn machinery is
dependent on rafts. These observations are in agreement with our previous study showing that
AChR and rapsyn expressed transiently in COS-7 cells also partitioned in DRMs (22).
Our finding that AChR as well as other synaptic proteins are included within rafts is
consistent with the accumulation of cholesterol and GM1 ganglioside in AChR-rich
postsynaptic membranes purified from Torpedo electric tissue (54, 55), and with freeze-
fracture data of filipin-treated rat myotubes in which spontaneous AChR clusters appear
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enriched in cholesterol (56). Cholesterol is also important for AChR function as it preserves
agonist-induced affinity state transitions (57). Moreover, the physical state of the AChR-rich
postsynaptic membrane from Torpedo as studied by Electron Spin Resonance (58, 59) showed
that the protein-vicinal lipids are immobile relatively to the rest of the membrane lipids. Our
findings are also in keeping with recent reports showing that several neurotransmitter
receptors and ion channels are biochemically located in lipid DRMs and that cholesterol is
required for their maintenance at postsynaptic sites or dendritic spines (16).
In a recent publication (23) it was reported that agrin treatment results in an increase in
AChR association with lipid rafts. However, this assertion was based on fluorescence
experiments, the resolution of which (~200 nm) is far below the estimated size of individual
rafts (10 to 50 nm). As such, it is not possible to deduce from these experiments whether
AChRs reside in rafts before clustering. Yet, DRM fractions obtained from untreated
myotubes in various extraction conditions (Triton X-100, pH 11 and Ca++Mg++ buffer)
contained robust amounts of AChR and we were not able to detect any difference in the
distribution patterns of AChRs along the gradients between control and agrin-treated
myotubes. These findings suggest that the association of AChRs with DRM is not dependent
on agrin. This observation was not surprising since rafts participate in intracellular trafficking
and surface targeting of AChR (22). In addition, cells defective in sphingolipid biosynthesis
express low amounts of cell surface AChRs (60). Since intracellular trafficking and surface
targeting of AChR are not likely to be controlled by agrin, the AChRs delivered to the cell
surface are very likely constitutively embedded in rafts. Collectively, the present data lead to
the notion that agrin activation regulates the coalescence of AChR-containing rafts rather than
the recruitment of AChR to rafts.
Considered as platforms for concentrating individual receptors activated by ligand
binding, rafts are believed to play important roles at the cell surface through signal
transduction (48, 61). Besides the formation of the immunological synapse (62, 63, 64), many
other signaling pathways including EGF, GNDF and Ras signaling (48), tyrosine
phosphorylation (12), and signaling through phosphatidylinositol-4, 5-bisphosphate (65, 66)
rely on lipid rafts. In this view, the occurrence of several effectors of the agrin signaling
pathway leading to AChR clustering such as MuSK, rapsyn and syntrophin in DRMs is of
interest. Accumulating evidence indicate that rafts are too small to engage in membrane
function. To trigger signaling transduction processes, they should usually have to cluster. An
attractive hypothesis from the present work is that raft coalescence may be an important step
of the agrin-induced AChR clustering, through activation of MuSK. Given the small size of
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individual rafts, it is possible that each raft contains a different subset of proteins i.e. AChR,
MuSK or rapsyn. Upon agrin engagement, AChR clustering could occur when many rafts
cluster together forming a large platform where the proteins can meet. Activated platforms
could then recruit in a reversible and dynamic manner scaffolding and/or cytoskeletal proteins
that promote large raft assembly (67, 68). Along this line, it is worth noting that agrin-induced
AChR clustering depends on an actin-driven movement of AChR protein within the
sarcolemma (8) and that MuSK activation also triggers actin cytoskeleton reorganization via
activation of Rac/Cdc 42 (9, 69, 70). Yet, lipid rafts, as preferred platforms for membrane-
linked actin polymerization (68), might serve as nucleation sites for AChR clustering upon
MuSK signaling (see Figure 9). Raft-regulated AChR clustering process may also be
important for synapse specification by keeping raft-borne synaptic proteins in an “off” state,
to prevent undue AChR clustering outside synaptic sites.
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Legends to figures
Figure 1. Cholesterol is required to induce and maintain AChR clusters in C2C12
myotubes. Agrin-elicited AChR clusters were detected by FITC-conjugated -Bgtx labeling
in C2C12 myotubes (A, E). Cholesterol depletion by MCD post-agrin (10 mM, 30 min at
37°C, see Materials and Methods) induced the dispersion of agrin-induced AChR clusters into
patches of smaller size (B). Fluorescence intensity for AChR aggregates were plotted versus
relative distances along the main axis of myotubes corresponding to fig A and B, respectively
(C, D). Depletion of cholesterol before agrin treatment prevented the formation of AChR
aggregates at the surface of myotubes (F). Internal controls (A, F) were provided for each set
of experiments. Bar =10 μm.
Figure 2. Membrane condensation at agrin-induced AChR clusters in C2C12
myotubes. Laurdan-labeled C2C12 myotubes were simultaneously imaged for the Laurdan
intensity in two channels (400-450 nm and 450-530 nm) using 2-photon laser scanning
microscopy and for Alexa 555-conjugated -Bgtx. Intensity images were converted to GP
images as described in Materials and Methods. A,D, G and J Global Polarization images were
pseudo-coloured for low and high GP from blue to yellow, respectively (scale in A). B, E, H
and K show the confocal images of Alexa 555--Bgtx staining of AChRs of the same fields
and focal depth as the corresponding GP images. C, F, I, L show plot profiles of the
fluorescence intensity of the toxin (blue, left y axis) and the GP values (red, right GP axis)
along the blue line indicated in B, E, H, K, respectively. A-C: control myotubes, D-F: agrin
treated myotubes, G-I: MßCD pre-agrin , J-L: MßCD post-agrin. The plot profile in F
disclosed high GP corresponding to two AChR clusters (open arrows) and an AChR cluster
with low GP (filled arrow). Note that GP values of MßCD-treated myotubes fall down to
control values (compare red plots in I, L with C).
Figure 3. DRM association of AChR, syntrophin and rapsyn in non-ionic detergent
extracts of C2C12 myotubes. (A) Distributions of cholesterol, proteins and GM1 across the
sucrose step gradient. Protein and cholesterol content of each fraction were determined as
indicated in Materials and Methods, and normalized to 1, according to their respective
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maximal values. For GM1 distribution along the gradient, dot blots were revealed out using
CTX and anti-CTX antibodies followed by ECL detection. (B) Western blots showing the
distribution of caveolin-3, flotillin-2/ESA, AChR (-subunit), syntrophin, rapsyn, transferrin
receptor and tubulin along the sucrose density gradients performed after extraction of
myotubes on ice with Triton X-100 (1/1 Triton/protein ratio : wt/wt). AChR and syntrophin
comigrated with the two raft markers in light fractions (4 to 6 =5/30% interface), well
separated from non-raft transferrin receptor and tubulin recovered in the heavy fractions (9-
12) at the bottom of gradient. Small amounts of rapsyn were also recovered in the DRM
fractions.
Figure 4. Alkaline extraction of DRMs from C2C12 myotubes. (A) Distributions of
cholesterol, proteins and GM1 across the sucrose step gradient after carbonate extraction of
C2C12 myotubes. Cholesterol, GM1 and total protein profiles appear similar to those
obtained following Triton X-100 extraction. (B) AChR partitioned in the light fractions (4 to
6) as did flotillin-2 and caveolin-3. Rapsyn was partially recovered in the DRM fractions.
Figure 5. Isotonic Ca
++
/Mg
++
extraction of DRMs from C2C12 myotubes. (A)
Distributions of cholesterol, proteins and GM1 across an expanded sucrose step gradient after
isotonic Ca
++
/Mg
++
extraction. Cholesterol-enriched fractions were recovered in the 30% and
35% layers together with AChR and raft marker flotillin-2 (B). Note that in this expanded
gradient, GM1 ganglioside-enriched membranes float with a slight shift towards light
fractions.
Figure 6. Electron micrographs of DRM fractions from C2C12 myotubes. Negatively
stained AChR-rich DRM fractions from the three different purification protocols (A= Triton
X100, B= isotonic cation buffer, C= pH 11).
Figure 7. Absence of effect of agrin on DRM association of AChR. The effect of agrin
on the distribution of AChR in step gradients following Triton X-100, pH 11, and Ca
++
Mg
++
buffer was monitored by Western blotting. To minimize individual culture or extraction
variations, control and agrin treated myotubes were strictly processed in the same conditions.
In the Triton X-100 extraction conditions, we selected an experiment in which AChR was
recovered both in light and heavy fractions to optimize the detection of a possible differential
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AChR partitioning between DRM and non-DRM. The stars indicated the position of the
AChR -subunit (42 kDa).
Figure 8. AChR aggregates independently of caveolin-3 and flotillin-2/ESA-enriched
microdomains in agrin-treated C2C12 myotubes. FITC--Bgtx labeling of AChR clusters
(green fluorescence) did not coincide with anti-caveolin-3 (A, B) or anti-flotillin-2/ESA (C)
labelings (red fluorescence). Merged images are shown. Bar = 10μm.
Figure 9. Model of postsynaptic apparatus formation by agrin –elicited raft
coalescence at the neuromuscular junction. Rafts containing various components of the
postsynaptic membrane (AChR, MuSK, rapsyn, syntrophin, etc…) were assembled and sorted
in the exocytic compartments (1), transported within vesicles (2), and targeted to the cell
surface, via microtubules (3). Tyrosine phosphorylation of MuSK by nerve-secreted agrin
would induce actin-driven coalescence of AChR-containing rafts through reorganization of
the actin cytoskeleton (4). Alternatively, it is possible that each raft accommodates a different
subset of proteins i.e. AChR, MuSK or rapsyn. Upon agrin engagement, AChR clustering
could occur when many rafts cluster together forming a large platform where the proteins can
meet. Abbreviations: DG= dystroglycan, MT= microtubule, PM= postsynaptic membrane,
PY= phosphotyrosine, TV= transport vesicle.
Table
Mean GP values ± standard deviations at AChR cluster membranes in agrin-treated and after
cholesterol depletion of C2C12 myotubes.
Mean GP value of ‘receptor clusters’
- agrin 0.234 ± 0.028 (n=24)
a,b
+ agrin 0.303 ± 0.088 (n=38)
a,c,d
+ agrin, Laurdan labelling at 18˚C 0.312 ± 0.065 (n=15)
b
mßCD post-agrin 0.255 ± 0.071 (n=20)
c
mßCD pre-agrin 0.262 ± 0.058 (n=21)
d
Pairs of a, b indicate P<0.001; c, d indicate P<0.05. All experiments were carried out at
37°C, except if indicated.
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